AMYLIN PHARMACEUTICALS INC Future Amortization Expense, Year Three (Deprecated 2012-01-31)
AMYLIN PHARMACEUTICALS INC reported Future Amortization Expense, Year Three (Deprecated 2012-01-31) of $26.22 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearThree · last filed 2012-02-22
- AMYLIN PHARMACEUTICALS INC future amortization expense, year three (deprecated 2012-01-31) for fiscal 2011 was $26.22M.
| Period end | Future Amortization Expense, Year Three (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $26.22M 10-K · filed 2012-02-22 |